Larger studies emphasizing AML subtypes according to FAB or WHO classification and AML cytogenetic subgroups are needed to clarify whether RAD21 methylation status is associated with biologically distinct AML subtypes. This evidence concerns the gene RAD21 and acute myeloid leukemia.